B-cell epitopes from the cancer testis antigen NY-ESO-1 [1]

International Journal of Cancer

Volumn 118, Issue 1, 2006, Pages 253-

  Preuss, Klaus Dieter ^a   Regitz, Evi ^a   Neumann, Frank ^a   Pfreundschuh, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NY ESO 1 ANTIGEN; RECOMBINANT PROTEIN; TUMOR ANTIGEN;

ALGORITHM; AMINO ACID ANALYSIS; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; B LYMPHOCYTE; BREAST CANCER; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROPHILICITY; LETTER; LUNG NON SMALL CELL CANCER; MELANOMA; PREDICTION; PRIORITY JOURNAL; SURFACE PROPERTY; TESTIS CANCER;

ALGORITHMS; ANTIGENS, NEOPLASM; B-LYMPHOCYTES; EPITOPES; HUMANS; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SOFTWARE;

EID: 27944434640     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21314     Document Type: Letter

References (3)

1. Zeng G, Aldridge ME, Wang Y, Pantuck AJ, Wang AY, Liu YX, Han Y, Yuan YH, Robbing PF, Dubinett SM, deKernion JB, Belldegrun AS. Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker. Int J Cancer 2005;114:268-73.
2. Neumann F, Wagner C, Kubuschok B, Stevanovic S, Rammensee HG, Pfreundschuh M. Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes. Cancer Immunol Immunother 2004;53:589-99.
3. Held G, Matsuo M, Epel M, Gnjatic S, Ritter G, Lee SY, Tai TY, Cohen CJ, Old LJ, Pfreundschuh M, Reiter Y, Hoogenboom HR, Renner C. Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments. Eur J Immunol 2004;34:2919-29.